Modularity of the metabolic gene network as a prognostic biomarker for hepatocellular carcinoma
F. Ye, D. Jia, M. Lu, H. Levine, M. Deem
This study identifies modularity in metabolic gene expression as a prognostic biomarker for hepatocellular carcinoma, correlating higher modularity with worse patient outcomes.
bioRxiv · Dec 26, 2017Cancer Biology